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.2012.09.Abstract Background: We hypothesized that NMDA antagonist, amantadine, may be beneﬁcial
in reducing the intraoperative a nesthetic and analgesic requirements. The aim of this study to eval-
uate the effect of preoperative oral amantadine on induction doses of propofol, intraoperative anes-
thetic and analgesic requirements.
Methods: In a prospective, randomized, double-blinded controlled study 60 female patients ASA I
or II aged 18–60 years old, planned for abdominoplasty surgery divided into two groups (30 patients
each). Group A: received oral amantadine 200 mg on the evening before surgery and 200 mg 60 min
prior to surgery. Group P (control group): the patients received placebo capsules. Propofol and iso-
ﬂurane were titrated guided by BIS during induction and maintenance of anesthesia where the total
dose of propofol and the time elapsed between injection of propofol to achieve BIS value 60 were
recorded. Also, the inspired isoﬂurane concentrations required to maintain BIS between 40 and 60
and the total dose of fentanyl needed to maintain adequate analgesia were recorded.
Results: The induction dose of propofol and the time from propofol injection till BIS value reached 60,
the total intraoperative fentanyl requirements and the inspired isoﬂurane concentration required tomain-
tain BIS reading between 40 and 60 were statistically signiﬁcant lower in amantadine group compared to
placebo treated group. The two groups were similar regarding the occurrence of side effects.r Alshifa Hospital, Hawally,
(A. Abdelmawgoud).
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8 A. Abdelmawgoud, S. RashwanConclusion: Preoperative oral amantadine reduced the induction time, induction dose of propofol, intra-
operative anesthetic and analgesic requirements compared to placebo without serious side effects in
female patients during abdominoplasty.
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The N-methyl-d-aspartate (NMDA) receptor activation by
excitatory neurotransmitters as aspartate or glutamate increase
in intracellular calcium with activation of second messengers
that modify neuronal excitability with development of central
sensitization of the dorsal horn neurons in response to noxious
stimulus [1].
The NMDA receptor antagonists have been shown to
potentiate the potency of volatile anesthetics in animal study
[2] and useful in prevention of central sensitization, and opi-
oid-induced hyperalgesia leading to decrease of the postopera-
tive pain and analgesic consumption [3].
Amantadine (1-aminoadamantane), a non-competitive
NMDA antagonist, was used for long time for treatment of
Parkinsonism and as an antiviral against inﬂuenza. It has been
found that perioperative oral amantadine reduced postopera-
tive pain and analgesic requirements [1].
To our knowledge there were no reports evaluating the ef-
fect of amantadine on intraoperative anesthetic and analgesic
requirements, therefore we hypothesized that the amantadine
as a NMDA antagonist might be beneﬁcial in reducing the
intraoperative anesthetic and analgesic requirements. This
study was designed in a prospective, randomized, double-
blinded controlled manner to evaluate the effect of preopera-
tive oral amantadine 200 mg on the evening before surgery
and 200 mg capsule 60 min prior to surgery on induction doses
of propofol, intraoperative anesthetic requirements guided by
BIS and intraoperative analgesic requirements.1.1. Methods
After approval of the local ethical committee, a written
informed consent obtained from 60 female patients American
Society of Anesthesiology (ASA) physical status I or II aged
18–60 years old, planned for abdominoplasty under general
anesthesia in Dar Alshifa hospital (State of Kuwait) from
January 2010 to January 2011.
Patients with ASA class more than II were excluded from
the study; patients with history of allergy to amantadine or
ingestion of dextromethorphan (cough suppressant) within
48 h before surgery were also excluded.
In the preoperative visit, the patients were informed about
the study protocol.
Patients were randomly divided to two equally divided
groups (30 patients each) by using the closed envelop tech-
nique. To maintain the blind nature of the study, the studied
drugs were prepared by an anesthesia nurse according to the
instructions written in a sealed envelope and were given to
the patients by the ward nurses as follows:
 Amantadine group (group A): the patients received
oral amantadine using the dose used in the study ofSnijdelaar et al. 200 mg capsule on the evening before
surgery and 200 mg capsule 60 min prior to surgery
(Symmetrel, Novartis pharma AG., Basel,
Switzerland).
 Placebo group (group P) (control group): the patients
received placebo capsules.
No sedative premedication were given to the patients.
When the patients reached the operation room, an 18 gauge
intravenous cannula was inserted and the monitors including
ECG, pulse oximetry, non-invasive blood pressure, and skin
temperature were attached. The depth of anesthesia was mon-
itored using the Bispectral index (BIS) monitoring, where the
BIS electrodes were placed on the forehead and were con-
nected to the BIS monitoring system (Aspect Medical Systems,
Leiden, The Netherlands).
In this study, both propofol and isoﬂurane were titrated
guided by BIS in a standardized technique to evaluate the ef-
fect of amantadine premedication on intraoperative anesthetic
requirements.
General anesthesia was induced using fentanyl 1 lg kg1
and propofol titration using the regimen used by Turkistani
et al. [4] where propofol was administered in 10 mg boluses
over 5 s every 15 s till the BIS value reached 60 where the
time taken to reach this value was recorded and the total
dose of propofol required to achieve this value was recorded.
Cisatracurium 0.15 mg kg1 was given and the trachea was
intubated with oral cuffed tube lubricated with lidocaine jell
2% 2 min after cisatracurium administration; controlled
ventilation was adjusted to maintain end-tidal CO2 35–
40 mmHg. Anesthesia was maintained with isoﬂurane 1.2%
in 50% N2O/O2 mixture with adjustment of the isoﬂurane
to maintain BIS value between 40 and 60 in order to main-
tain adequate depth of anesthesia. Analgesia was maintained
by fentanyl 50 lg when signs of inadequate analgesia (>20%
increase in the heart rate and mean arterial blood pressure
from the baseline) were observed. Muscle relaxation was
maintained with cisatracurium boluses in response to periph-
eral nerve stimulator.
At the end of surgery, isoﬂurane and N2O were discontin-
ued and muscle relaxant was reversed by atropine and neostig-
mine. Following extubation, patients were transferred to the
recovery room where patients were monitored until they ful-
ﬁlled the criteria of the modiﬁed Alderate scores.
The following were evaluated by an anesthesiologist una-
ware of the studied groups:
(1) Demographic data and duration of surgery.
(2) Induction dose of propofol.
(3) Time from propofol injection till BIS value reached 60
(T1).
(4) The inspired isoﬂurane concentrations at BIS value 40–
60 were collected every 10 min and the mean isoﬂurane
concentration during the procedure were recorded.
Table 1 Patient characteristics and operative data.
Group (P) (n= 30) Group (A) (n= 30)
Age (years) 47(4) 48(4)
Weigh (kg) 86(4.2) 82(3.4)
Amantadine and intraoperative anesthetic and analgesic requirements 9(5) The total dose of intraoperative fentanyl needed to
maintain adequate analgesia.
(6) Time for BIS value to reach 80 following isoﬂurane dis-
continuation (T2).
(7) Postoperative side effects such as.
ASA physical status (I/II) 19/11 20/10
Operation time (min) 106(8) 103(9)
Group P: Placebo group, Group A: amantadine group. Data pre-
sented as mean (SD), number.
No signiﬁcant differences between the studied groups.– Nausea and vomiting (treated with ondansetron 4–
8 mg i.v.).
– Sedation (graded on a ﬁve-point scale: 1: fully awake
and oriented; 2: drowsy; 3: eyes closed, arousable to
command; 4: eyes closed, arousable to physical stim-
ulation; and 5: eyes closed, unrousable to physical st-
imulation) [5].
– Respiratory depression.Table 2 Time from propofol injection till BIS value reached
60 and Time for BIS value to reach 80 following isoﬂurane
discontinuation.
Group (P) (n= 30) Group (A) (n= 30)
T1 (sec) 97(1.4) 86(1.3)*
T2 (min) 5.3(0.4) 5.7(0.6)
Group P: Placebo group, Group A: amantadine group. Data pre-
sented as mean (SD). T1: time from propofol injection till BIS value
reached 60, T2: time for BIS value to reach 80 following isoﬂurane
discontinuation.
* Signiﬁcant difference compared to group P (p< 0.05).1.2. Statistical analysis
The sample size in this study was calculated similar to that in
the study of Turkistani et al. taking the propofol dose required
to decrease the BIS to below 60 as the primary outcome with
the power was set at 85% and the a-error level was ﬁxed at
0.05. Data values were presented as means (SD) or number
(percentages). Numerical data were analyzed by using Stu-
dent’s unpaired t-test. Nonparametric data were analyzed by
using the Mann Whitney U-test. A value of P< 0.05 was con-
sidered signiﬁcant. All statistical analysis was performed using
(Microsoft Excel 2003).Table 3 Doses of propofol, fentanyl and Isoﬂurane.
Group (P) Group (A)2. Results
There were no signiﬁcant differences between the two studied
groups regarding age, sex, ASA state and duration of surgery
(Table 1).
During induction, the induction dose of propofol and the
time from propofol injection till BIS value reached 60 was sta-
tistically signiﬁcant lower in amantadine group compared to
placebo treated group (p< 0.05) without signiﬁcant difference
between the two groups in the time for BIS value to reach 80
following isoﬂurane discontinuation (Table 2).
During maintenance of anesthesia, total intraoperative fen-
tanyl requirements and inspired isoﬂurane concentration re-
quired to maintain BIS reading between 40 and 60 were
statistically signiﬁcant lower in amantadine group compared
to placebo treated group (p< 0.05) (Table 3).
There were no signiﬁcant differences between the two stud-
ied groups regarding perioperative heart rate and mean arterial
blood pressure at different time of measurements (Figs. 1 and 2).
Nausea developed in four patients in amantadine group
and ﬁve patients in placebo treated group without statistically
signiﬁcant difference between two groups, with development of
vomiting in one patient of the amantadine group without
occurrence of sedation or respiratory depression in the two
studied groups (Table 4).(n= 30) (n= 30)
Induction dose of propofol (mg) 168(13.4) 126(9.6)*
Total intraoperative fentanyl (lg) 133.8(6.9) 83.8(7.3)*
Inspired isoﬂurane concentration (%) 1.7(0.07) 1.1(0.08)*
Group P: Placebo group, Group A: amantadine group. Data pre-
sented as mean (SD).
* Signiﬁcant difference compared to group P (p< 0.05).3. Discussion
This study demonstrates that oral premedication with amanta-
dine 200 mg on the evening of surgery and 200 mg 60 min prior
to surgery reduced the induction time and dose of propofol and
intraoperative isoﬂurane consumption required to reduce theBIS reading to 40–60 compared to placebo treated patients.
This is consistent with the ﬁnding of the animal study of Daniell
who reported that NMDA antagonists potentiate the general
anesthetics [2].
In this study, BIS monitoring was used because it can be
considered a useful method of detecting inadequate sedation,
analgesia, or both during general anesthesia [6].
To our knowledge few studies are available evaluating the
analgesic effect of amantadine, therefore; we used reports of
other NMDA antagonists to compare our ﬁndings.
The ability of NMDA antagonists to reduce pain is contro-
versial, some reports were inconsistence with our ﬁndings; the
study of Snijdelaar and colleagues reported that perioperative
oral amantadine 200 mg on the evening before surgery; 200 mg
at 1 h before surgery; and 100 mg at 8, 20, and 32 h after surgery
decreased postoperative pain and morphine requirements
after radical prostatectomy [1]. Kawamata et al. [7] found that
preoperative oral dextromethorphan decreased pain and anal-
gesic consumption after tonsillectomy in adults, Abu-Samara
and Ismaeil [8] found that oral dextromethorphan adminis-
trated 90 min before surgery decreased postoperative pain
after functional endoscopic sinus surgery. Heidari et al. [9]
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Figure 1 Perioperative heart rate (HR) in the two studied groups, No signiﬁcant differences between the studied groups.
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Figure 2 Perioperative mean arterial blood pressure (MAP) in the two studied groups, No signiﬁcant differences between the studied
groups.
Table 4 Postoperative side effects.
Group (P) (n= 30) Group (A) (n= 30)
Nausea 5(16%) 4(13%)
Vomiting 0(0) 1(3%)
Sedation 0(0) 0(0)
Respiratory depression 0(0) 0(0)
Group P: Placebo group, Group A: amantadine group. Data pre-
sented as number (percentage).
No signiﬁcant differences between the studied groups.
10 A. Abdelmawgoud, S. Rashwanfound that oral ketamine was effective in reducing postopera-
tive pain and analgesic requirements after orthopedic surgery.
In addition Seyhan et al. [10] concluded that i.v. magnesium
sulfate reduced intraoperative anesthetic and postoperative
analgesic requirements. Also, Ryu and colleagues [11] reported
that i.v. magnesium sulfate reduced postoperative analgesic
consumption.
The mechanism by which NMDA antagonists may reduce
pain and opioid consumption, by preventing the development
of central sensitization to noxious stimulus and reducing opi-
oid tolerance in many animal and human studies [3].
Contrary to the previous studies; Gottschalk et al. [12]
reported that preoperative intravenous 200 mg of amantadine
given 30 min before surgery did not reduce the postoperative
opioid requirements in women undergoing abdominal hyster-
ectomy, this may be due to the difference in the amantadine
dose and route (two oral doses in our study and single intrave-
nous dose in Gottschalk et al. study) and the type of surgery
being extra abdominal surgery in our study, Rose et al. [13]
concluded that preoperative oral dextromethorphan 1 h before
surgery has no opioid sparing effect in children after adenoton-
sillectomy and Mahmoodzadeh et al. [14] found that oral dex-
tromethorphan administrated two hours before surgery, did
not decrease postoperative pain intensity and morphine
requirement after cholecystectomy.
Further studies are required to study the effect of different
doses of amantadine on intraoperative anesthetic requirements.
We concluded that preoperative oral amantadine 200 mg
on the evening of surgery and 200 mg 60 min before surgery re-
duced the induction time, induction dose of propofol, intraop-erative anesthetic and analgesic requirements compared to
placebo in female patients during abdominoplasty surgery.
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